Continuing Medical Education (CME)

 
 
UEMS logoContinuing Medical Education (CME)
The 17th ESASO Retina Academy 2017 has been accredited with 14 ECMEC Credits by the European Accreditation Council for Continuing Medical Education (EACCME).

European Accreditation
CME accreditation granted by the UEMS-EACCME® provides a guarantee to participants from all over the world that the content of the CME provided is of a high quality, unbiased and didactic and, for European doctors, that this quality will be recognized in their home country.

About EACCME
The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Conversion of EACCME credits to AMA credits
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Conflicts of Interest of the Members of the Scientific and Organising Committees

In accordance with criterion 24 of document UEMS 2012/30 “Accreditation of Live Educational Events by the EACCME”, these are the potential conflicts of interest of the members of the Scientific and Organising Committees for the last three years:

Francesco Bandello, MD
University Vita-salute, Scientific Institute San Raffaele, Milan, Italy
Receipt of honoraria/consultation fee from the commercial companies Allergan, Alcon, Alimera Sciences, Bausch and Lomb, Bayer, Boehringer Ingelheim, Farmila-Thea, Genentech, Hoffmann La-Roche, Novagali Pharma, Novartis, Sanofi-Aventis, Santen, Sifi, Sooft, Thrombogenics, Zeiss

Maurizio Battaglia Parodi, MD
University Vita-salute, Scientific Institute San Raffaele, Milan, Italy
No potential conflict of interest to report

Neil M. Bressler, MD
Johns Hopkins University School of Medicine, Baltimore, USA
Receipt of grant/research support from the commercial companies Bayer, Genentech/Roche, Lumenis, Novartis, Optovue, Regeneron, Samsung

Borja Corcóstegui, MD
Institut de Microcirurgia Ocular (IMO), Spain
Receipt of honoraria/consultation fee from the commercial companies Allergan, Bausch Lomb

Bruno Falcomatà, MD
Azienda Ospedaliera “B.M.M.”, Reggio Calabria, Italy
No potential conflict of interest to report

Giuseppe Guarnaccia, MD
European School for Advanced Studies in Ophtalmology, Lugano, Switzerland
No potential conflict of interest to report

Antonia Joussen, MD
Charité – Universitätismedizin Berlin, Germany
Receipt of research support and honoraria or consultation fees from commercial companies Bayer, Novartis